These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20921463)

  • 1. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.
    Pardo Y; Guedea F; Aguiló F; Fernández P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Craven-Bratle J; Suárez JF; Boladeras A; Pont À; Ayala A; Sancho G; Martínez E; Alonso J; Ferrer M
    J Clin Oncol; 2010 Nov; 28(31):4687-96. PubMed ID: 20921463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary obstructive problems exposed but hormonal health-related quality-of-life concerns eschewed in prostate cancer quality-of-life study.
    Sanda MG
    J Clin Oncol; 2010 Nov; 28(31):4667-8. PubMed ID: 20921452
    [No Abstract]   [Full Text] [Related]  

  • 3. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course and predictors of symptoms after primary prostate cancer therapy.
    Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
    J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
    Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
    Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
    Hedgepeth RC; Labo J; Zhang L; Wood DP
    J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB; Bissonette EA; Theodorescu D
    BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical prostatectomy in the treatment of prostate cancer.
    Epperson WJ
    Am Fam Physician; 1998 Dec; 58(9):1972, 1977-8. PubMed ID: 9861875
    [No Abstract]   [Full Text] [Related]  

  • 11. Promising long-term health-related quality of life after high-dose-rate brachytherapy boost for localized prostate cancer.
    Wahlgren T; Nilsson S; Lennernäs B; Brandberg Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):662-70. PubMed ID: 17499452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality of life after radiotherapy for prostate cancer].
    Joly F; Degrendel AC; Guizard AV
    Cancer Radiother; 2010 Oct; 14(6-7):519-25. PubMed ID: 20728393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.
    Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
    Jpn J Clin Oncol; 2008 Jul; 38(7):480-5. PubMed ID: 18621847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.
    Miller DC; Sanda MG; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin WP; Wei JT
    J Clin Oncol; 2005 Apr; 23(12):2772-80. PubMed ID: 15837992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is radical prostatectomy the "gold standard" for localized prostate cancer?
    Mendenhall WM; Nichols RC; Henderson R; Mendenhall NP
    Am J Clin Oncol; 2010 Oct; 33(5):511-5. PubMed ID: 20010078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual quality of life following radical prostatectomy in men with prostate cancer.
    Willener R; Hantikainen V
    Urol Nurs; 2005 Apr; 25(2):88-90, 95-100. PubMed ID: 15900977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 3-y prospective study of health-related and disease-specific quality of life in patients with nonmetastatic prostate cancer treated with radical prostatectomy or external beam radiotherapy.
    Yoshimura K; Arai Y; Ichioka K; Matsui Y; Ogura K; Terai A
    Prostate Cancer Prostatic Dis; 2004; 7(2):144-51. PubMed ID: 15111981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining sexual outcomes after treatment for localized prostate carcinoma.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness of the University of California-Los Angeles Prostate Cancer Index.
    Bergman J; Saigal CS; Kwan L; Litwin MS
    Urology; 2010 Jun; 75(6):1418-23. PubMed ID: 19589573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' perspectives on fecal incontinence after brachytherapy for localized prostate cancer.
    Lamb MN; Trabinino L; Hackford A
    Dis Colon Rectum; 2011 May; 54(5):615-21. PubMed ID: 21471764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.